Literature DB >> 25359365

The international serious adverse events consortium.

Arthur L Holden1, Jorge L Contreras2, Sally John3, Matthew R Nelson4.   

Abstract

The International Serious Adverse Events Consortium is generating novel insights into the genetics and biology of drug-induced serious adverse events, and thereby improving pharmaceutical product development and decision-making.

Mesh：

Year:  2014        PMID： 25359365     DOI： 10.1038/nrd4441

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


  2 in total

1.  The SNP consortium: summary of a private consortium effort to develop an applied map of the human genome.

Authors:  Arthur L Holden
Journal:  Biotechniques       Date:  2002-06       Impact factor: 1.993

2.  The International Serious Adverse Events Consortium's data sharing model.

Authors:  Jorge L Contreras; Aris Floratos; Arthur L Holden
Journal:  Nat Biotechnol       Date:  2013-01       Impact factor: 54.908
  2 in total
  6 in total

Review 1.  Global implementation of genomic medicine: We are not alone.

Authors:  Teri A Manolio; Marc Abramowicz; Fahd Al-Mulla; Warwick Anderson; Rudi Balling; Adam C Berger; Steven Bleyl; Aravinda Chakravarti; Wasun Chantratita; Rex L Chisholm; Vajira H W Dissanayake; Michael Dunn; Victor J Dzau; Bok-Ghee Han; Tim Hubbard; Anne Kolbe; Bruce Korf; Michiaki Kubo; Paul Lasko; Erkki Leego; Surakameth Mahasirimongkol; Partha P Majumdar; Gert Matthijs; Howard L McLeod; Andres Metspalu; Pierre Meulien; Satoru Miyano; Yaakov Naparstek; P Pearl O'Rourke; George P Patrinos; Heidi L Rehm; Mary V Relling; Gad Rennert; Laura Lyman Rodriguez; Dan M Roden; Alan R Shuldiner; Sukdeb Sinha; Patrick Tan; Mats Ulfendahl; Robyn Ward; Marc S Williams; John E L Wong; Eric D Green; Geoffrey S Ginsburg
Journal:  Sci Transl Med       Date:  2015-06-03       Impact factor: 17.956

Review 2.  Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  World J Hepatol       Date:  2015-07-08

Review 3.  Predictive validity in drug discovery: what it is, why it matters and how to improve it.

Authors:  Jack W Scannell; James Bosley; John A Hickman; Gerard R Dawson; Hubert Truebel; Guilherme S Ferreira; Duncan Richards; J Mark Treherne
Journal:  Nat Rev Drug Discov       Date:  2022-10-04       Impact factor: 112.288

4.  Genome-wide Association Study Identified Chromosome 8 Locus Associated with Medication-Related Osteonecrosis of the Jaw.

Authors:  Guang Yang; Sonal Singh; Caitrin W McDonough; Jatinder K Lamba; Issam Hamadeh; L Shannon Holliday; Danxin Wang; Joseph Katz; Peter A Lakatos; Bernadett Balla; Janos P Kosa; Gian Andrea Pelliccioni; Douglas K Price; Sara L Van Driest; William D Figg; Taimour Langaee; Jan S Moreb; Yan Gong
Journal:  Clin Pharmacol Ther       Date:  2021-08-31       Impact factor: 6.903

Review 5.  Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.

Authors:  Simran D S Maggo; Ruth L Savage; Martin A Kennedy
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

Review 6.  Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis.

Authors:  Teri A Manolio; Carolyn M Hutter; Mark Avigan; Ricardo Cibotti; Robert L Davis; Joshua C Denny; Lois La Grenade; Lisa M Wheatley; Mary N Carrington; Wasun Chantratita; Wen-Hung Chung; Andrea D Dalton; Shuen-Iu Hung; Ming Ta Michael Lee; J Steven Leeder; Juan J L Lertora; Surakameth Mahasirimongkol; Howard L McLeod; Maja Mockenhaupt; Michael Pacanowski; Elizabeth J Phillips; Simone Pinheiro; Munir Pirmohamed; Cynthia Sung; Wimon Suwankesawong; Lauren Trepanier; Santa J Tumminia; David Veenstra; Rika Yuliwulandari; Neil H Shear
Journal:  Clin Pharmacol Ther       Date:  2017-11-06       Impact factor: 6.875
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.